Global Artificial Intelligence (AI) in Biotechnology 麻豆原创 Research Report 2023

Publication ID:

PB504242630

Publication Date:

April 27, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

AI in biotech is critical for boosting invention in labs and throughout a medicine's or chemical compound's lifecycle. AI-based tools and applications aid in the development of molecule structures per the target market. Machine learning, a subset of artificial intelligence, aids in estimating combinations and permutations of different compounds to determine the best combination without the need for manual experiments in the lab. Artificial intelligence's application in biotech brings about innovations that aid predictive modeling to forecast market demand for a specific drug or chemical. AI in Biotech can also assist in the smart distribution of raw materials needed by the biotech sector via cloud computing.
The global Artificial Intelligence (AI) in Biotechnology market was valued at US$ 2919 million in 2022 and is anticipated to reach US$ 9367.4 million by 2029, witnessing a CAGR of 21.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Artificial Intelligence (AI) in Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Artificial Intelligence (AI) in Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Artificial Intelligence (AI) in Biotechnology in Agriculture Biotechnology is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Artificial Intelligence (AI) in Biotechnology include AstraZeneca, Abbott Laboratories, Amgen, Inc., Atomwise, Biogen, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc and Johnson & Johnson Services, Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence (AI) in Biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence (AI) in Biotechnology.
The Artificial Intelligence (AI) in Biotechnology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Artificial Intelligence (AI) in Biotechnology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence (AI) in Biotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AstraZeneca
Abbott Laboratories
Amgen, Inc.
Atomwise
Biogen
Bristol-Myers Squibb
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc
Johnson & Johnson Services, Inc.
Pfizer, Inc.
Merck KGaA
Novo Nordisk A/S
Novartis AG
Sanofi
Segment by Type
Hardware
Software and Services
Segment by Application
Agriculture Biotechnology
Medical Biotechnology
Animal Biotechnology
Industrial Biotechnology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence (AI) in Biotechnology companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Hardware
1.2.3 Software and Services
1.3 麻豆原创 by Application
1.3.1 Global Artificial Intelligence (AI) in Biotechnology 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Agriculture Biotechnology
1.3.3 Medical Biotechnology
1.3.4 Animal Biotechnology
1.3.5 Industrial Biotechnology
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Biotechnology 麻豆原创 Perspective (2018-2029)
2.2 Artificial Intelligence (AI) in Biotechnology Growth Trends by Region
2.2.1 Global Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Intelligence (AI) in Biotechnology Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Artificial Intelligence (AI) in Biotechnology Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Artificial Intelligence (AI) in Biotechnology 麻豆原创 Dynamics
2.3.1 Artificial Intelligence (AI) in Biotechnology Industry Trends
2.3.2 Artificial Intelligence (AI) in Biotechnology 麻豆原创 Drivers
2.3.3 Artificial Intelligence (AI) in Biotechnology 麻豆原创 Challenges
2.3.4 Artificial Intelligence (AI) in Biotechnology 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence (AI) in Biotechnology Players by Revenue
3.1.1 Global Top Artificial Intelligence (AI) in Biotechnology Players by Revenue (2018-2023)
3.1.2 Global Artificial Intelligence (AI) in Biotechnology Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Artificial Intelligence (AI) in Biotechnology 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence (AI) in Biotechnology Revenue
3.4 Global Artificial Intelligence (AI) in Biotechnology 麻豆原创 Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Biotechnology 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Biotechnology Revenue in 2022
3.5 Artificial Intelligence (AI) in Biotechnology Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence (AI) in Biotechnology Product Solution and Service
3.7 Date of Enter into Artificial Intelligence (AI) in Biotechnology 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence (AI) in Biotechnology Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Biotechnology Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Artificial Intelligence (AI) in Biotechnology Forecasted 麻豆原创 Size by Type (2024-2029)
5 Artificial Intelligence (AI) in Biotechnology Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Biotechnology Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Artificial Intelligence (AI) in Biotechnology Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size (2018-2029)
6.2 North America Artificial Intelligence (AI) in Biotechnology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size by Country (2018-2023)
6.4 North America Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size (2018-2029)
7.2 Europe Artificial Intelligence (AI) in Biotechnology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size by Country (2018-2023)
7.4 Europe Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Artificial Intelligence (AI) in Biotechnology 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size (2018-2029)
9.2 Latin America Artificial Intelligence (AI) in Biotechnology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Artificial Intelligence (AI) in Biotechnology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Intelligence (AI) in Biotechnology 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Artificial Intelligence (AI) in Biotechnology Introduction
11.1.4 AstraZeneca Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Artificial Intelligence (AI) in Biotechnology Introduction
11.2.4 Abbott Laboratories Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.2.5 Abbott Laboratories Recent Development
11.3 Amgen, Inc.
11.3.1 Amgen, Inc. Company Detail
11.3.2 Amgen, Inc. Business Overview
11.3.3 Amgen, Inc. Artificial Intelligence (AI) in Biotechnology Introduction
11.3.4 Amgen, Inc. Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.3.5 Amgen, Inc. Recent Development
11.4 Atomwise
11.4.1 Atomwise Company Detail
11.4.2 Atomwise Business Overview
11.4.3 Atomwise Artificial Intelligence (AI) in Biotechnology Introduction
11.4.4 Atomwise Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.4.5 Atomwise Recent Development
11.5 Biogen
11.5.1 Biogen Company Detail
11.5.2 Biogen Business Overview
11.5.3 Biogen Artificial Intelligence (AI) in Biotechnology Introduction
11.5.4 Biogen Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.5.5 Biogen Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Detail
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Artificial Intelligence (AI) in Biotechnology Introduction
11.6.4 Bristol-Myers Squibb Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Company Detail
11.7.2 F. Hoffmann-La Roche Ltd. Business Overview
11.7.3 F. Hoffmann-La Roche Ltd. Artificial Intelligence (AI) in Biotechnology Introduction
11.7.4 F. Hoffmann-La Roche Ltd. Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.7.5 F. Hoffmann-La Roche Ltd. Recent Development
11.8 Gilead Sciences, Inc
11.8.1 Gilead Sciences, Inc Company Detail
11.8.2 Gilead Sciences, Inc Business Overview
11.8.3 Gilead Sciences, Inc Artificial Intelligence (AI) in Biotechnology Introduction
11.8.4 Gilead Sciences, Inc Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.8.5 Gilead Sciences, Inc Recent Development
11.9 Johnson & Johnson Services, Inc.
11.9.1 Johnson & Johnson Services, Inc. Company Detail
11.9.2 Johnson & Johnson Services, Inc. Business Overview
11.9.3 Johnson & Johnson Services, Inc. Artificial Intelligence (AI) in Biotechnology Introduction
11.9.4 Johnson & Johnson Services, Inc. Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.9.5 Johnson & Johnson Services, Inc. Recent Development
11.10 Pfizer, Inc.
11.10.1 Pfizer, Inc. Company Detail
11.10.2 Pfizer, Inc. Business Overview
11.10.3 Pfizer, Inc. Artificial Intelligence (AI) in Biotechnology Introduction
11.10.4 Pfizer, Inc. Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.10.5 Pfizer, Inc. Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Detail
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Artificial Intelligence (AI) in Biotechnology Introduction
11.11.4 Merck KGaA Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.11.5 Merck KGaA Recent Development
11.12 Novo Nordisk A/S
11.12.1 Novo Nordisk A/S Company Detail
11.12.2 Novo Nordisk A/S Business Overview
11.12.3 Novo Nordisk A/S Artificial Intelligence (AI) in Biotechnology Introduction
11.12.4 Novo Nordisk A/S Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.12.5 Novo Nordisk A/S Recent Development
11.13 Novartis AG
11.13.1 Novartis AG Company Detail
11.13.2 Novartis AG Business Overview
11.13.3 Novartis AG Artificial Intelligence (AI) in Biotechnology Introduction
11.13.4 Novartis AG Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.13.5 Novartis AG Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Detail
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Artificial Intelligence (AI) in Biotechnology Introduction
11.14.4 Sanofi Revenue in Artificial Intelligence (AI) in Biotechnology Business (2018-2023)
11.14.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

AstraZeneca
Abbott Laboratories
Amgen, Inc.
Atomwise
Biogen
Bristol-Myers Squibb
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc
Johnson & Johnson Services, Inc.
Pfizer, Inc.
Merck KGaA
Novo Nordisk A/S
Novartis AG
Sanofi

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.